Loss of Antidepressant Efficacy During Maintenance Therapy: Possible Mechanisms and Treatments
The DOI matches its Crossref record.
Abstract
BACKGROUND: Many patients with unipolar depression experience a return of depressive symptoms while taking a constant maintenance dose of an antidepressant. METHOD: All cited studies were found using computerized literature searches of the MEDLINE database since 1966. RESULTS: The return of depressive symptoms during maintenance antidepressant treatment has occurred in 9% to 57% of patients in published trials. Possible explanations include loss of placebo effect, pharmacologic tolerance, increase in disease severity, change in disease pathogenesis, the accumulation of a detrimental metabolite, unrecognized rapid cycling, and prophylactic inefficacy. CONCLUSION: Although several strategies have been proposed to overcome the loss of antidepressant efficacy, double-blind controlled studies are needed to ascertain the optimal strategy for this perplexing clinical problem.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with the return of depressive symptoms of MDD occurring in 9-33% of patients across published trials [3].”
In the citing paper
“For instance, it was postulated that the activation of processes driving tolerance to antidepressant drugs may occur to at varying degrees in every patient receiving antidepressants [3], may only manifest themselves and then be recognized in patients with chronic and recurrent forms of depression who had previously responded to antidepressant therapy at some time [37].”
Citations
Cites
Still being checked.
Cited by
Items 101–161 of 161
Panacea or Placebo: The Historical Quest for Medications to Treat Depression
Overholser, J. C. (2006) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-006-9023-z · Cited by 8
LADER, M. H. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18500-7_7 · Cited by 7
Treatments for Depression: Wisdom Imparted from Treatments Discarded
Overholser, J. C. (2002) · The International Journal of Psychiatry in Medicine · doi:10.2190/89hb-8gxd-06xc-5bqk · Cited by 7
Obtaining Informed Consent When a Profession Labels Itself as Providing Treatment for Mental Illness
Littrell, J. L. (2003) · Social Work in Mental Health · doi:10.1300/j200v01n04_07 · Cited by 6
Tardive dysphoria: antidepressant-induced chronic depression
El‐Mallakh, R. S., Roberts, R. J., Swann, A. C., Rutherford, P. R., & Surja, A. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700011976 · Cited by 6
Cavalcanti, S., Lopez, O. A., Kung, S., Voort, J. L. V., Somers, K. J., Frye, M. A., & Singh, B. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001839 · Cited by 5
The Controversy Over Antidepressant Drugs in an Era of Evidence-Based Practice
Littrell, J. L., & Lacasse, J. R. (2012) · Social Work in Mental Health · doi:10.1080/15332985.2012.699444 · Cited by 4
Psychosomatic medicine:alive and well in the new century
Fava, G. A., Fabbri, S., Belaise, C., & Tossani, E. (2002) · Revista Portuguesa de Psicossomática · Cited by 4
Fava, G. A. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001468 · Cited by 4
The role of cognitive behavioural therapy in the treatment of unipolar depression
Fava, G. A., Ottolini, F., & Ruini, C. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb07249.x · Cited by 4
Haupt, M. J., Carra, S., Boehnke, K. F., & Aday, J. S. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111634 · Cited by 3
Coping with the catch-22s of depression: A guide for educating patients
Allen, J. G. (2002) · Bulletin of the Menninger Clinic · doi:10.1521/bumc.66.2.103.23360 · Cited by 3
Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling
Datta, V., & Cleare, A. J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.10 · Cited by 3
Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 3
Mindfulness-based Yoga intervention for women with elevated levels of depressive symptoms
Schuver, K. J. (2014) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 3
Environmental Factors in Panic Disorder
Asnis, J., Faisal, A., & Sanderson, W. C. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0412g · Cited by 3
Analysis of tolerance to antidepressant drug treatment in FDA Adverse Event Reporting System
Carnovale, C., Gentili, M., Viganò, C. A., Carnaghi, G., Beltrami, M., & Bosi, M. F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.013 · Cited by 3
Hategan, A., & Bourgeois, J. A. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001701 · Cited by 3
Li, X., Wang, X., Xue, L., Luo, L., Hu, L., & Jiang, W. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115540 · Cited by 2
Cognitive-Behavioral Therapy for Depression
Abreu, N., Powell, V. B., & Sudak, D. M. (2012) · InTech eBooks · doi:10.5772/30200 · Cited by 2
Application of Pharmacogenomics to Clinical Problems in Depression
Oestergaard, S., & M⊘ldrup, C. (2009) · Personalized Medicine · doi:10.2217/pme.09.32 · Cited by 2
de Oliveira, C. M. (2021) · theses.fr (ABES) · doi:10.70675/7291a4e5z9949z4fd4za27dze7f18385347b · Cited by 2
Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1 · Cited by 1
Können Antidepressiva den langfristigen Verlauf depressiver Erkrankungen negativ verändern?
Gründer, G., Mertens, L. J., Spangemacher, M., & Schmitz, C. N. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01801-1 · Cited by 1
Гарибова, Т. Л., Крайнева, В. А., Вальдман, Е. А., Гудашева, Т. А., Олеговна, К. С., & Середенин, С. Б. (2018) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf16128-33 · Cited by 1
Deprescribing Antidepressant Medications in Major Depressive Disorder
Gupta, S., Miller, R. A., & Cahill, J. D. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190654818.003.0008 · Cited by 1
Kessler, N. H. (2018) · AESS interdisciplinary environmental studies and sciences series · doi:10.1007/978-3-319-99274-7_9 · Cited by 1
Antidepressant-Antianxiety Agents
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_4 · Cited by 1
Reply to "Obsessive-Compulsive Symptoms With Risperidone"
Saxena, S. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0412d · Cited by 1
Treatment Selection: Understanding What Works for Whom in Mental Health
Cohen, Z. D. (2018) · ScholarlyCommons (University of Pennsylvania) · Cited by 1
Reply to "Obsessive-Compulsive Symptoms With Risperidone"
Andrade, C. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0412c · Cited by 1
Die Bedeutung des Gesamtbehandlungsplanes für die Behandlung affektiver Störungen
Gastpar, M., & Nebe, J. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6150-0_14
Abusus/Abhängigkeit, Toleranz, Absetzsyndrome
Laux, G., & Dietmaier, O. (2006) · Elsevier eBooks · doi:10.1016/b978-343721063-1.50019-6
Antidepressiva läkemedels effekt på frakturrisk, hjärt-kärlsystemet och sjukdomsprognos
Hildingsson, J. (2013) · DiVA (Linnaeus University)
Murphy, M. P. (2006) · Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
Fabbri, S. (2007) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/279
Characterization, treatment, and prevention of stress-induced psychopathology
Brachman, R. A. (2014) · doi:10.7916/d84b2zwq
Santone, G., Bellantuono, C., & Psichiatrica, C. (2009) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology
Pharmacology and neuroimaging of antidepressant action
Dunlop, B. W., Lecrubier, Y., & Fossati, P. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00038-3
This issue: A Paradigm Shift in Depression Treatment
Farah, A. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150901-03
Reasons of the Heart: Neuroscience and the Ethics of Consent
Charland, L. C. (2006)
Androgens and neuroplasticity : contributions to the pathogenesis and treatment of depression
Wainwright, S. R. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0221360
Reply to "Can Long-Term Antidepressant Use Be Depressogenic?"
Rothschild, A. J., & Byrne, S. E. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0412f
Self-citationMcLaughlin, P., & Cleare, A. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.009
Ebenezer, I. S. (2015) · Wiley eBooks · doi:10.1002/9781118385777.refs
Möller, H., Grunze, H., Hegerl, U., Henkel, V., Bauer, M., Laux, G., Boerner, R. J., Broocks, A., Kordon, A., Hohagen, F., et al. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6150-0_11
Laux, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_55
Laux, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_55
Goldberg, J. F. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.023
The sequential approach to treating recurrent depression shows promise in some patients
&NA; (2004) · Drugs & Therapy Perspectives · doi:10.2165/00042310-200420100-00004
Fantin, M. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2022.tde-28042022-155300
Digvijaya, Mittal, S., Mittal, P., Singh, R., Gupta, S., Singh, T., Khan, R., Alzobaidi, N., & Alhalmi, A. (2024) · Scientifica · doi:10.1155/2024/9978076
Gründer, G. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21199-7.00002-7
Chapter 2. Unipolar and Bipolar Depression
Rothschild, A. J. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378166.lg02
Self-citation(2005) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377572.bm02
Akuttherapie depressiver Störungen
Laux, G., & Dietmaier, O. (2006) · Elsevier eBooks · doi:10.1016/b978-343721063-1.50023-8
Rodríguez-Gaztelumendi, A. (2010) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Figueiredo, A. L. R. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/dwz9-9q22
Tremblay, L. K. (2002) · TSpace (University of Toronto)
Gupta, K. (2026) · TSpace (University of Toronto)
Nicht-selektive Monoamin- Rückaufnahme-Inhibitoren (NSMRI)
Laux, G., Fritze, J., König, W., Dietmaier, O., & König, F. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6150-0_3
Metadata
- Authors
- Byrne, S. E., & Rothschild, A. J.
- Affiliations
- Cambridge Hospital (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1998-06-15
- Volume
- 59
- Issue
- 6
- Pages
- 279-288
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2083405172
- Cited by
- 149
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 1 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 9 · 2014: 7 · 2013: 3 · 2012: 6
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Institutes of Health (7r29mh047457-06)
- National Institute of Mental Health (MH-47457)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- antidepressant efficacy, maintenance therapy, relapse, major depressive disorder, placebo effect, rapid cycling, antidepressant metabolites, prophylaxis, disease severity
- MeSH terms
- Adult, Aged, Antidepressive Agents, Antidepressive Agents, Tricyclic, Clinical Trials as Topic, Depressive Disorder, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Drug Tolerance, Female, Humans, Male, Middle Aged, Monoamine Oxidase Inhibitors, Research Design, Severity of Illness Index, United States, Placebo Effect, MEDLINE, Selective Serotonin Reuptake Inhibitors, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.